Education
About Us
Working with TipRanks
Follow Us
Mazen Darwazah Insider Profile
4 Followers
Mazen Darwazah, Vice Chairman & President at Hikma Pharmaceuticals, holds 1.97M shares in Hikma Pharmaceuticals (Ticker: GB:HIK). Most recently, Mazen Darwazah Bought 315,000 shares of Hikma Pharmaceuticals on Nov 07, 2025 for an estimated value of 5.04M.
Mazen Darwazah Hikma Pharmaceuticals (HIK)Vice Chairman & President
Hikma Pharmaceuticals (HIK)
Vice Chairman & President
Ranked #52,434 out of 104,449 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-0.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Vice Chairman & President
Roles that Mazen Darwazah holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 13, 2019 - Mar 13, 2020
Return:+10.80%
The most profitable trade made by Mazen Darwazah
Mazen Darwazah's Trading History
List of latest transactions for each holding click on a transaction to see Mazen Darwazah's performance on stock
You May Also Like
Mazen Darwazah insider profile FAQ
What is the percentage of profitable transactions made by Mazen Darwazah?
The percentage of profitable transactions made by Mazen Darwazah is 25%.
What is the average return per transaction made by Mazen Darwazah?
The average return per transaction made by Mazen Darwazah is -0.10%.
What stocks does Mazen Darwazah hold?
Mazen Darwazah holds: GB:HIK stocks.
What was Mazen Darwazah’s latest transaction?
Mazen Darwazah latest transaction was an Informative Buy of 5.04M.
What was Mazen Darwazah's most profitable transaction?
Mazen Darwazah’s most profitable transaction was an Informative Buy of GB:HIK stock on March 13, 2019. The return on the trade was 10.80%.
What is Mazen Darwazah's role in Hikma Pharmaceuticals?
Mazen Darwazah's role in Hikma Pharmaceuticals is Vice Chairman & President .
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.